Skip to main content
Let's spread the word about Immunotherapy! Click to share this page with your community.

World Cancer Day: The Many Languages of Cure

February 02, 2015

Cancer can affect anyone, anywhere. World Cancer Day is both a celebration of the progress we've made so far, and a call to do more to reduce cancer-related deaths worldwide.

Since 1953, Cancer Research Institute (CRI) has funneled $282 million in breakthrough research across many different types of cancers, around the world in search for treatments that save lives—and potentially cure cancer. We have funded 3,000 scientists and have laid the groundwork for immunotherapy treatments in laboratories and clinics across Australia, Brazil, Canada, Israel, Japan, Russia, Sweden, United States, and many more countries.

So we wanted to say something simple that articulates the global span of working toward a cure. From Bengali to Ukrainian, our scientists, from all around the world, shared what we all hope to see: an end to all cancers within our lifetimes.

Featured scientists include:

  • Gosse Adema (Clinic and Laboratory Integration Program (CLIP) grantee) and Group, Radboud University Medical Centre, Nijmegen, The Netherlands
  • Matteo Bellone (CLIP grantee) and Group, Fondazione Centro San Raffaele, Milan, Italy
  • Enzo Cerundolo (Scientific Advisory Council and clinical trials network member) and Group, MRC Human Immunology Unit, University of Oxford, Oxford, United Kingdom
  • Carmen Gerlach (CRI postdoctoral fellow) and Group, Harvard Medical School, Boston, MA
  • Michael Goldberg (CLIP grantee), Dana-Farber Cancer Institute, Boston, MA
  • Priya Issuree and Mo Xu (CRI postdoctoral fellows), NYU Langone Medical Center, New York, NY
  • Dirk Jäger (clinical trials network member), National Center for Tumor Diseases, University Clinic of Heidelberg, Heidelberg, Germany
  • Elke Jäger and Julia Karbach (clinical trials network members), Krankenhaus Nordwest, Frankfurt, Germany
  • Rakesh Jain (CLIP grantee) and Group, Massachusetts General Hospital, Boston, MA
  • George Klein (grantee and Scientific Advisory Council member) and Group, Karolinska Institute, Stockholm, Sweden
  • Alex Knuth (grantee and Scientific Advisory Council member) and Colleague, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar
  • Simon Laban (clinical trials network member) and Group, University of Ulm, Ulm, Germany
  • Yoshi Nishikawa (grantee) and Group, Osaka University, Osaka, Japan

Cancer immunotherapy can one day help us reach our goal. You can help us get there sooner by making a donation today at bit.ly/give2worldcure.

Be in the know with the latest immunotherapy news

*Immunotherapy results may vary from patient to patient.

Top